Vaccines against RNA Viruses

RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (166 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546232504498
ctrlnum (CKB)5400000000044451
(oapen)https://directory.doabooks.org/handle/20.500.12854/69449
(EXLCZ)995400000000044451
collection bib_alma
record_format marc
spelling Saiz, Juan Carlos edt
Vaccines against RNA Viruses
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (166 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast number of different approaches, from purified inactivated and live attenuated viruses, nucleic acid (DNA or RNA) based candidates, virus-like particles, subunit elements, and recombinant viruses are been employed to combat viruses. However, for many of them efficient vaccines are not yet available. This will probably change dramatically with the current Covid-19 pandemic, as a vast variety of vaccinology approaches are being tested against it, with hundreds of candidates under development, dozens of them already in clinical trials, a fact that is breaking records in vaccine development and implementation. This is becoming possible thanks to the enormous work carried out during years to have the bases for a quick response, even against unknown pathogens, in an impressive short time. Here, results obtained with different vaccine´s methodological approaches against human (HIV, HCV, HRV) animal (PRRSV, PEDV, FMDV, VHSV) and zoonotic (RVF, WNV), RNA viruses are presented by field experts.
English
Medicine bicssc
artificial protein
polyepitope B- and T-cell HIV-1 immunogen
epitopes of broadly neutralizing HIV-1 antibodies
peptide mimic of discontinuous epitope
immunogenicity
birds
vaccines
West Nile virus
flavivirus
herd immunity
porcine epidemic diarrhea virus
RNA interference
processivity factor
intestine epithelial cells
N gene
rotavirus nanoparticle vaccine
gnotobiotic pigs
FMDV
peptide vaccine
single dose
amount
pig
VHSV
non-virion (NV)
transcriptome profiling
rainbow trout
immune pathways
Rift Valley fever virus (RVFV)
modified vaccinia Ankara (MVA)
cellular response
neutralizing antibodies
Gn Gc glycoproteins
passive serum:virus transfer
hepatitis C virus
neutralising antibodies
animal models
immune responses
PRRSV Mosaic T-cell DNA vaccine VACV
PRRS
cross protection
heterologous virus challenge
3-03943-623-6
3-03943-624-4
Saiz, Juan Carlos oth
language English
format eBook
author2 Saiz, Juan Carlos
author_facet Saiz, Juan Carlos
author2_variant j c s jc jcs
author2_role Sonstige
title Vaccines against RNA Viruses
spellingShingle Vaccines against RNA Viruses
title_full Vaccines against RNA Viruses
title_fullStr Vaccines against RNA Viruses
title_full_unstemmed Vaccines against RNA Viruses
title_auth Vaccines against RNA Viruses
title_new Vaccines against RNA Viruses
title_sort vaccines against rna viruses
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (166 p.)
isbn 3-03943-623-6
3-03943-624-4
illustrated Not Illustrated
work_keys_str_mv AT saizjuancarlos vaccinesagainstrnaviruses
status_str n
ids_txt_mv (CKB)5400000000044451
(oapen)https://directory.doabooks.org/handle/20.500.12854/69449
(EXLCZ)995400000000044451
carrierType_str_mv cr
is_hierarchy_title Vaccines against RNA Viruses
author2_original_writing_str_mv noLinkedField
_version_ 1787548726838951938
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03640nam-a2200781z--4500</leader><controlfield tag="001">993546232504498</controlfield><controlfield tag="005">20231214133249.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044451</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69449</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044451</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Saiz, Juan Carlos</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccines against RNA Viruses</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (166 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast number of different approaches, from purified inactivated and live attenuated viruses, nucleic acid (DNA or RNA) based candidates, virus-like particles, subunit elements, and recombinant viruses are been employed to combat viruses. However, for many of them efficient vaccines are not yet available. This will probably change dramatically with the current Covid-19 pandemic, as a vast variety of vaccinology approaches are being tested against it, with hundreds of candidates under development, dozens of them already in clinical trials, a fact that is breaking records in vaccine development and implementation. This is becoming possible thanks to the enormous work carried out during years to have the bases for a quick response, even against unknown pathogens, in an impressive short time. Here, results obtained with different vaccine´s methodological approaches against human (HIV, HCV, HRV) animal (PRRSV, PEDV, FMDV, VHSV) and zoonotic (RVF, WNV), RNA viruses are presented by field experts.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">artificial protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyepitope B- and T-cell HIV-1 immunogen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epitopes of broadly neutralizing HIV-1 antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide mimic of discontinuous epitope</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunogenicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">birds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">West Nile virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">flavivirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">herd immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">porcine epidemic diarrhea virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RNA interference</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">processivity factor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intestine epithelial cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">N gene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rotavirus nanoparticle vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gnotobiotic pigs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FMDV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptide vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">single dose</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">amount</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pig</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VHSV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-virion (NV)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transcriptome profiling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rainbow trout</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rift Valley fever virus (RVFV)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">modified vaccinia Ankara (MVA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cellular response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutralizing antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gn Gc glycoproteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">passive serum:virus transfer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis C virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutralising antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">animal models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune responses</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PRRSV Mosaic T-cell DNA vaccine VACV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PRRS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross protection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heterologous virus challenge</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-623-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-624-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saiz, Juan Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338192340004498&amp;Force_direct=true</subfield><subfield code="Z">5338192340004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338192340004498</subfield></datafield></record></collection>